A digital view of the world illustrates how Astellas is a global company committed to serving patients worldwide.

News

Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.

Month Year

Nov 18, 2016

Antihypertensive Drug "Micatrio® Combination Tablets"

Nippon Boehringer Ingelheim Co., Ltd. (Head Office: Tokyo; President and Representative Director: Yoshiaki Aono, hereafter “Nippon Boehringer Ingelheim”) and Astellas Pharma Inc. (Head Office:...

Read more
Nov 11, 2016

Astellas Transfers Its Global Dermatology Business to LEO Pharma

Read more
Nov 9, 2016

GUINNESS WORLD RECORDSTM Title Achieved for Organ Donor Registrations

Astellas, Donate Life America and World Transplant Games Federation Celebrate Achievements for Global Transplant Community at History-making Rugby Match

TOKYO and CHICAGO, Ill. – Nov. 9 2016 – Astellas Pharma Inc. (TSE: 4503, collectively with its subsidiaries “Astellas”), Donate Life America and the World Transplant Games Federation today...

Read more
Nov 1, 2016

Astellas Announces Status of Acquisition of Own Shares

(Under the provision of its Articles of Incorporation in accordance with Article 165, paragraph 2 of the Companies Act)

Read more
Oct 30, 2016

Astellas Announces Acquisition of Own Shares

(Under the provision of its Articles of Incorporation in accordance with Article 165, paragraph 2 of the Companies Act)

Read more

Show per page

Discover more

Media contacts

Return to media homepage

Subscribe to news alerts

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa

Choose Language

News